Department of Nephrology, ABVIMS, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Department of Cardiology, ABVIMS, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
J Vasc Access. 2024 Sep;25(5):1567-1575. doi: 10.1177/11297298231161461. Epub 2023 Jun 15.
Arteriovenous Fistula (AVF) surveillance is required to detect early dysfunction (thrombosis, stenosis) and its timely correction prolongs access-patency. Clinical examination (CE) and doppler have been used as screening/surveillance of AVF, for early detection of AVF dysfunction. Since there was inadequate evidence for KDOQI to make recommendations on AVF surveillance and on secondary failure rate. We compared CE, doppler and fistulogram as surveillance modalities in detecting a secondary failure in matured AVF.
This prospective-observational, single-center study, was done between December 2019-April 2021. CKD stage 5 patients on dialysis/Not-on-dialysis with matured AVF were included at third month. CE, doppler (blood flow, vein diameter, depth), and fistulogram were done at third and sixth month. Secondary failure was assessed at sixth month classifying AVF to patent/functional and failed group. Diagnostic tests were performed by comparing three methods considering fistulogram as gold-standard. Residual urine output is also monitored to look for any contrast induced residual renal function loss.
Of total 407 created AVF, 98 (24%) had primary failure. Twenty-five (6%) had surgical complications including unsuccessful AVF and aneurysm/rupture, 156 lost follow-up at third month, 104 consented patients were enrolled, 16 lost to follow-up subsequently, and 88 patients' data were analyzed at the end. At the sixth month, 76(86.4%) had patent AVF, 8 (9.1%) had secondary failure (Thrombosis-4, Central Venous Stenosis-4), and 4 (4.1%) patients expired. Considering fistulogram as a diagnostic standard, CE showed 87.5% sensitivity, and 93.4% specificity (cohen's kappa value of 0.66). Doppler had sensitivity and specificity of 87% and 96% respectively (cohen's kappa value of 0.75), Combination of clinical examination with doppler showed sensitivity and specificity of 100% and 89% respectively.
Although the secondary AVF failure rate is less than the primary, CE is an important and valuable tool in the diagnosis and surveillance of AVF in detecting its dysfunction. Moreover, CE with doppler can be used as a surveillance protocol that can detect early AVF dysfunction at par with Fistulogram.
动静脉瘘(AVF)监测是为了检测早期功能障碍(血栓形成、狭窄),并及时纠正以延长通路通畅性。临床检查(CE)和多普勒超声已被用于 AVF 的筛查/监测,以早期发现 AVF 功能障碍。由于 KDOQI 没有足够的证据来推荐 AVF 监测和继发性失功率。我们比较了 CE、多普勒超声和瘘管造影作为成熟 AVF 中检测继发性失败的监测方式。
这是一项前瞻性观察性、单中心研究,于 2019 年 12 月至 2021 年 4 月进行。纳入透析/未透析的慢性肾脏病 5 期患者,在第 3 个月时 AVF 成熟。第 3 个月和第 6 个月进行 CE、多普勒超声(血流、静脉直径、深度)和瘘管造影。第 6 个月时,根据瘘管造影将 AVF 评估为通畅/功能正常和失败组。通过比较三种方法,以瘘管造影为金标准,评估继发性失败。还监测残余尿量,以观察是否有造影剂诱导的残余肾功能丧失。
在总共 407 例创建的 AVF 中,98 例(24%)发生了原发性失败。25 例(6%)发生了手术并发症,包括 AVF 不成功和动脉瘤/破裂,156 例患者在第 3 个月时失访,104 例患者同意入组,随后 16 例失访,最终 88 例患者的数据进行了分析。在第 6 个月时,76 例(86.4%)AVF 通畅,8 例(9.1%)发生继发性失败(血栓形成 4 例,中心静脉狭窄 4 例),4 例(4.1%)患者死亡。以瘘管造影为诊断标准,CE 的灵敏度为 87.5%,特异性为 93.4%(Cohen's kappa 值为 0.66)。多普勒超声的灵敏度和特异性分别为 87%和 96%(Cohen's kappa 值为 0.75),CE 与多普勒超声联合的灵敏度和特异性分别为 100%和 89%。
尽管继发性 AVF 失败率低于原发性,但 CE 是检测 AVF 功能障碍的重要和有价值的工具。此外,CE 联合多普勒超声可以作为一种监测方案,与瘘管造影一样,可以早期检测 AVF 功能障碍。